MedTech Dive January 22, 2024
Most participants reported a significant reduction in overstimulation compared to open-loop spinal cord stimulation.
Dive Brief:
- Medtronic’s closed-loop spinal cord stimulation (SCS) technology has reduced overstimulation in a clinical trial, the company said last week at the North American Neuromodulation Society annual meeting in Las Vegas.
- Most (89%) of the 28 participants reported a significant reduction in overstimulation compared to open-loop SCS, and 86% expressed a preference for closed-loop during blinded testing at one month.
- Medtronic’s closed loop SCS device, Inceptiv, has a CE Mark but is not currently approved in the U.S. Saluda Medical received approval for a closed-loop system that adjusts stimulation in response to feedback from the body in 2022, but the open-loop method remains the...
Today's Sponsors
Today's Sponsor
Topics: Medical Devices